SCHEMBL5225545

SCHEMBL5225545

CC(=O)OC(=O)C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.77
MAPT P10636 8/20 0.77
CYP3A4 P08684 7/20 0.77
RXRA P19793 5/20 0.77
RARA P10276 4/20 0.77
RARB P10826 4/20 0.77
RARG P13631 4/20 0.77
PTGS1 P23219 4/20 0.77
MAPK1 P28482 4/20 0.77
HIF1A Q16665 4/20 0.77
APP P05067 4/20 0.77
SNCA P37840 4/20 0.77
ALOX15 P16050 4/20 0.77
HSD17B10 Q99714 4/20 0.77
BLM P54132 3/20 0.77
LMNA P02545 3/20 0.77
MEN1 O00255 3/20 0.77
KMT2A Q03164 3/20 0.77
RXRB P28702 2/20 0.77
RXRG P48443 2/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11125160 1.00 ALDH1A1 (0.77) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL21587 1.00 ALDH1A1 (0.77) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL1362317 0.95 ALDH1A1 (0.80) ALDH1A1MAPTCYP3A4RXRARARA
Ether SCHEMBL7892945 0.94 ALDH1A1 (0.68) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL7523937 0.93 ALDH1A1 (0.77) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL7890783 0.93 ALDH1A1 (0.77) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL4862741 0.93 ALDH1A1 (0.77) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL27679011 0.92 ALDH1A1 (0.79) ALDH1A1MAPTCYP3A4RXRARARA
Alcohol SCHEMBL1362664 0.91 ALDH1A1 (0.73) ALDH1A1MAPTCYP3A4RXRARARA
SCHEMBL7892941 0.91 ALDH1A1 (0.73) ALDH1A1MAPTCYP3A4RXRARARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117981798-A Meal replacement milk shake and preparation method thereof 黑龙江谱华威乳业集团有限公司 2024-05-07 CN claimed
US-5514672-A Use of retinoids and compositions containing same for hair growth BAZZANO GAIL S (US) 1996-05-07 US claimed
US-5183817-A Synergistic stimulants to treat alopecia BAZZANO GAIL S (US) 1993-02-02 US claimed
EP-0071598-A4 THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. BAZZANO GAIL S 1983-06-08 EP claimed
EP-0071598-A1 THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS. BAZZANO GAIL S 1983-02-16 EP claimed
WO-1982002833-A1 THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FUR-BEARING ANIMALS BAZZANO GAIL SANSONE 1982-09-02 WO claimed
CN-117981798-A Meal replacement milk shake and preparation method thereof 黑龙江谱华威乳业集团有限公司 2024-05-07 CN disclosed
CN-117137008-A Pregnant woman and lactating mother nutrition supplementing composition and preparation method thereof 黑龙江飞鹤乳业有限公司 2023-12-01 CN disclosed
CN-116172083-A Total nutrient formula food for improving spleen and stomach functions and preparation method thereof 广东中北态生物科技有限公司 2023-05-30 CN disclosed
EP-1394161-B1 L-ASCORBIC ACID-2-O-MALEIC ACID-A-TOCOPHEROL DIESTER 1-PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME SENJU PHARMA CO (JP) 2007-04-18 EP disclosed
US-6828348-B2 Cosmetic component or ingredient, antioxidant, radical scavenger, anti-inflammatory agent or elastase inhibitor SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-12-07 US disclosed
US-20040171676-A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same SENJU PHARMACEUTICAL CO., LTD. (JP) 2004-09-02 US disclosed
EP-1394161-A9 L-ASCORBIC ACID-2-O-MALEIC ACID-A-TOCOPHEROL DIESTER 1-PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME Senju Pharmaceutical Co., Ltd. (JP) 2004-07-07 EP disclosed
EP-0711276-A1 PROCESS FOR THE PREPARATION OF N-(4-HYDROXYPHENYL)-RETINAMIDE ORTHO PHARMACEUTICAL CORPORATION (US) 1996-05-15 EP disclosed
US-5514672-A Use of retinoids and compositions containing same for hair growth BAZZANO GAIL S (US) 1996-05-07 US disclosed
US-5399757-A Process for the preparation of N-(4-hydroxyphenyl)-retinamide ORTHO PHARMACEUTICAL CORPORATION (US) 1995-03-21 US disclosed
WO-1995003274-A1 PROCESS FOR THE PREPARATION OF N-(4-HYDROXYPHENYL)-RETINAMIDE ORTHO PHARMACEUTICAL CORPORATION (US) 1995-02-02 WO disclosed
EP-0071598-B1 THE USE OF RETINOIDS AND THEIR DERIVATIVES TO INCREASE THE RATE OF GROWTH OF HUMAN SCALP HAIR AND TO INCREASE THE RATE OF GROWTH OF FUR IN CERTAIN FURBEARING ANIMALS BAZZANO, Gail S (US) 1990-05-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040171676-A1 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same TTPA, SERPINB1, ELANE ALDH1A1 126/4885MAPT 769/4885CYP3A4 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.